Abstract
Systemic corticosteroids (SCSs) have been widely used to treat various inflammatory respiratory diseases for many years despite the serious complications associated with them. Inhaled corticosteroids (ICSs) have been developed to reduce the harmful adverse effects of SCSs. Since their first introduction, ICSs have been used primarily for the treatment of asthma. However, certain individuals including those with chronic obstructive pulmonary disease or croup may respond to the beneficial effects of ICSs. In this review, we discuss the effectiveness of ICSs in the treatment of non-asthmatic inflammatory respiratory diseases in paediatric and adult populations.
Keywords: Adult, children, effectiveness, inflammation, inhaled corticosteroids, non-asthmatic respiratory diseases
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
Title:Success of Inhaled Corticosteroids in the Treatment of Non-Asthmatic Respiratory Diseases
Volume: 11 Issue: 3
Author(s): Nazan Cobanoglu
Affiliation:
Keywords: Adult, children, effectiveness, inflammation, inhaled corticosteroids, non-asthmatic respiratory diseases
Abstract: Systemic corticosteroids (SCSs) have been widely used to treat various inflammatory respiratory diseases for many years despite the serious complications associated with them. Inhaled corticosteroids (ICSs) have been developed to reduce the harmful adverse effects of SCSs. Since their first introduction, ICSs have been used primarily for the treatment of asthma. However, certain individuals including those with chronic obstructive pulmonary disease or croup may respond to the beneficial effects of ICSs. In this review, we discuss the effectiveness of ICSs in the treatment of non-asthmatic inflammatory respiratory diseases in paediatric and adult populations.
Export Options
About this article
Cite this article as:
Cobanoglu Nazan, Success of Inhaled Corticosteroids in the Treatment of Non-Asthmatic Respiratory Diseases, Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry 2012; 11 (3) . https://dx.doi.org/10.2174/1871523011202030210
DOI https://dx.doi.org/10.2174/1871523011202030210 |
Print ISSN 1871-5230 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-614X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Diabetic Complications and Insight into Antidiabetic Potentialities of Ethno- Medicinal Plants: A Review
Recent Patents on Inflammation & Allergy Drug Discovery Immunoregulatory Impact of Food Antioxidants
Current Pharmaceutical Design Recent Advances in Identification and Characterization of β-Adrenoceptor Agonists and Antagonists
Current Topics in Medicinal Chemistry Personalised Genetic Intervention for Duchenne Muscular Dystrophy: Antisense Oligomers and Exon Skipping
Current Molecular Pharmacology Targeting Adenosine Signaling to Treatment of Diabetic Nephropathy
Current Drug Targets Nitric Oxide: A Key Mediator of Biofilm Dispersal with Applications in Infectious Diseases
Current Pharmaceutical Design Substance P and its Inhibition in Ocular Inflammation
Current Drug Targets Nuclear Targeting of Gold Nanoparticles for Improved Therapeutics
Current Topics in Medicinal Chemistry Treating Neonatal Brain Injury - Promise and Inherent Research Challenges
Recent Patents on Inflammation & Allergy Drug Discovery Clinical Practice of Umbilical Cord Blood Stem Cells in Transplantation and Regenerative Medicine - Prodigious Promise for Imminent Times
Recent Patents on Biotechnology Use of Systemic Proteasome Inhibition as an Immune-Modulating Agent in Disease
Endocrine, Metabolic & Immune Disorders - Drug Targets Adenosine and Adenosine Receptors: Their Contribution to Airway Inflammation and Therapeutic Potential in Asthma
Current Medicinal Chemistry Evaluation of the Anthelmentic Activity of Garlic (Allium sativum) in Mice Naturally Infected with Aspiculuris tetraptera
Recent Patents on Anti-Infective Drug Discovery Chiral Kinase Inhibitors
Current Topics in Medicinal Chemistry Treatment of Hereditary Angioedema: Current Perspectives
Recent Patents on Inflammation & Allergy Drug Discovery Circadian Cycle and Chronotherapeutics: Recent Trend for the Treatment of Various Biological Disorders
Recent Patents on Drug Delivery & Formulation OMICS-Derived Targets for Inflammatory Gut Disorders: Opportunities for the Development of Nutrition Related Biomarkers
Endocrine, Metabolic & Immune Disorders - Drug Targets Choosing Optimal Firstline Helicobacter pylori Therapy: a View from a Region with High Rates of Antibiotic Resistance
Current Pharmaceutical Design Novel and Current Treatment Concepts Using Pulmonary Drug Delivery
Current Pharmaceutical Design Cardiovascular Disease: A Target for the Pharmacological Effects of Quercetin
Current Topics in Medicinal Chemistry